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In this study, we investigated the presence of plasmid-mediated quinolone resistance (PMQR) genes among 101 
ciprofloxacin-resistant urinary Escherichia coli isolates and searched for mutations in the quinolone-resistance-
determining regions (QRDRs) of the DNA gyrase and topoisomerase IV genes in PMQR-carrying isolates. Eight 
isolates harboured the qnr and aac(6’)-Ib-cr genes (3 qnrS1, 1 qnrB19 and 4 aac(6’)-Ib-cr). A mutational analysis of 
the QRDRs in qnr and aac(6’)-Ib-cr-positive isolates revealed mutations in gyrA, parC and parE that might be as-
sociated with high levels of resistance to quinolones. No mutation was detected in gyrB. Rare gyrA, parC and parE 
mutations were detected outside of the QRDRs. This is the first report of qnrB19, qnrS1 and aac(6’)-Ib-cr-carrying 
E. coli isolates in Brazil.
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Escherichia coli is a common cause of community-
acquired urinary tract infections (CA-UTIs). Quinolones 
have become the most frequently prescribed antimicro-
bials worldwide due to their broad-spectrum antimicro-
bial activity (Yang et al. 2010). However, in the last few 
decades, an increase in quinolone resistance has been 
documented among human and veterinary isolates of 
E. coli. Quinolone resistance among Enterobacteri-
aceae originally occurred due to chromosomal muta-
tions in the quinolone-resistance-determining regions 
(QRDRs) of the gyrA and gyrB genes, which encode the 
gyrase A and B subunits, respectively and the parC and 
parE genes, which encode topoisomerase IV subunits 
(Hernández et al. 2011). In addition to the chromosomal 
mutations in the QRDRs, plasmid-mediated quinolone 
resistance (PMQR) determinants may also reduce the 
levels of quinolone susceptibility; these elements were 
first described in 1998 (Martinez-Martinez et al. 1998, 
Robicsek et al. 2006a, Hernández et al. 2011). Over the 
last several years, different PMQR gene variants have 
been described in different locations worldwide. Never-
theless, few studies of PMQR genes have been conducted 
in Brazil. The first PMQR determinants were described 
by Castanheira et al. (2007) (qnrA) and by Minarini 
et al. (2008) (qnrB). The overuse of quinolones in the 
clinical setting may lead to treatment failure and a pub-
lic health risk; consequently, a better understanding of 
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PMQR genes is of fundamental importance. Therefore, in 
this study, we investigated the presence of the qnrA, qnrB, 
qnrS and aac(6’)-Ib-cr genes in a sample of ciprofloxacin-
resistant E. coli isolates from women with CA-UTIs.
A total of 101 ciprofloxacin-resistant E. coli isolates 
collected from the urine of women with clinical and lab-
oratory diagnoses of CA-UTI between May-November 
2009 in Belo Horizonte, Minas Gerais, Brazil, were in-
vestigated. Only one isolate per patient was included. 
These isolates were identified using an automated VI-
TEK 2 microbial identification system, version 04.02 
(bioMérieux), according to the manufacturer’s instruc-
tions. This study was approved by the Ethical Commit-
tee of the Federal University of Minas Gerais (178/09).
The minimum inhibitory concentration (MICs) of 
nalidixic acid, ciprofloxacin, ofloxacin, norfloxacin and 
levofloxacin (Sigma-Aldrich) for all aac(6’)-Ib-cr and 
qnr-positive isolates were determined using the agar di-
lution method (CLSI 2009). Screening for extended-spec-
trum beta-lactamase (ESBL) production was performed 
with the broth microdilution method using an automated 
VITEK 2 system, version 04.02 (bioMérieux), according 
to the CLSI (2009) guidelines. 
All isolates were screened for the presence of the 
qnrA, qnrB, qnrS and aac(6’)-Ib-cr genes using previ-
ously described primers and amplification conditions 
(Park et al. 2006, Robicsek et al. 2006b). The QRDRs 
of the chromosomal genes were amplified only from 
the aac(6’)-Ib-cr and qnr-positive isolates using previ-
ously described primers and conditions (Park et al. 2006, 
Morgan-Linnell et al. 2009). The PCR products were se-
quenced with a MegaBACE 1000 capillary sequencer. 
The predicted amino acid sequences of GyrA, GyrB, 
ParC and ParE were analysed to identify putative amino 
acid changes with respect to the wild-type protein se-
quences from E. coli K12 MG 1655 (GenBank accession 
49175990). The nucleotide sequences obtained have been 
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deposited in GenBank under the following accessions: 
qnrB19 (JF923528), aac(6’)Ib-cr (JF923529-JF923532), 
qnrS1 (JF923533-JF923535), gyrA (JN565698-JN565702 
and JN415087-JN415089), gyrB (JN565703-JN565710), 
parC (JN565711-JN565713 and JN657512-JN657516) 
and parE (JN565714-JN565721).
Eight of the 101 isolates evaluated (7.9%) harboured 
PMQR genes. Among the qnr-positive isolates, three con-
tained qnrS1 and one contained qnrB19. It should be not-
ed that no isolate harboured the qnrA gene, although the 
detection of this gene in Brazilian isolates was previously 
described by Castanheira et al. (2007). Few qnrS1 and 
qnrB19-positive E. coli isolates have been reported since 
2008 and most of these isolates were qnrB19-positive iso-
lates from South America (Deepak et al. 2009). In Brazil, 
the detection of the qnrA1 gene in E. coli (Castanheira et 
al. 2007) and of qnrB2 and qnrB8 genes in other Enter-
obacteriaceae (Minarini et al. 2008) has been described 
previously and the qnrB19 gene was recently detected for 
the first time in Salmonella isolated from poultry (Ferrari 
et al. 2011). Furthermore, four isolates in our study were 
aac(6’)-Ib-cr-positive. Although the aac(6’)-Ib-cr gene 
appears to be more prevalent overall than any of the qnr 
genes (Morgan-Linnell et al. 2009), we detected these 
genes at the same frequency in the present study. These 
findings conflict with the results of with previous stud-
ies, which indicated that qnrB was the most widespread 
PMQR in Brazil (Minarini et al. 2008). 
The analysis of the qnrS1, qnrB19 and aac(6’)-Ib-cr 
sequences revealed 100% identity to the reported qnrS1 
sequence from the IncN plasmid from the Salmonella 
enterica subsp. enterica strain 382/03 (GenBank acces-
sion HQ214119.1); 99% identity to the qnrB19 sequence 
from the E. coli plasmid p013.1 IncR (GenBank acces-
sion HM146784.1) and 100% identity to the aac(6’)-Ib-
cr sequence from the Shigella dysenteriae strain DS-505 
(GenBank accession HQ166949.1), respectively.
Sequence analysis of the chromosomal QRDR re-
vealed mutations in the gyrA, parC and parE genes. No 
gyrB mutation was detected. Most isolates exhibited 
double mutations in GyrA and single mutations in ParC 
and ParE (Table). Our results are in agreement with those 
of previous works, which showed that substitutions at 
S83 and D87 in gyrA and S80 in parC are common and 
lead to a high level of quinolone resistance (Hopkins et 
al. 2005, Sorlozano et al. 2007). Additionally, rare muta-
tions outside of the GyrA, ParC and ParE QRDRs were 
detected (Table); among these, only S458 in parE had 
been reported previously (Sorlozano et al. 2007, Moon 
et al. 2010, Bansal & Tandon 2011). This mutation was 
originally reported in Spain (Sorlozano et al. 2007) and 
was identified at a high frequency in E. coli isolates re-
covered in Delhi, India (Bansal & Tandon 2011). There 
have been few reports of uncommon mutations outside 
QRDRs (Friedman et al. 2001, Lindgren et al. 2003, Sor-
lozano et al. 2007) and the effects of such mutations on 
quinolone susceptibility should be studied further. 
The high observed MICs for quinolones (Table) were 
likely a consequence of mutations in the chromosomal 
QRDRs associated with PMQR genes. Previous works 
also suggested that PMQR and chromosomal resistance 
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mechanisms are additive and can enhance the quinolone 
resistance of clinical isolates (Martínez-Martínez et al. 
2003, Rodríguez-Martínez et al. 2011). Furthermore, it 
should be noted that PMQR genes may facilitate the emer-
gence of quinolone resistance, which would have thera-
peutic implications (Rodríguez-Martínez et al. 2011).
Recently, the association of aac(6’)-Ib-cr with 
genes encoding the beta-lactamase CTX-M-15 or other 
ESBLs has been reported (Pitout et al. 2008). There-
fore, we considered it important to analyse the ESBL 
production of PMQR-positive E. coli isolates. Only 
two of the eight PMQR-positive isolates screened pro-
duced ESBLs and both of these isolates were positive 
for aac(6’)-Ib-cr. To verify the horizontal mobility and 
potential capacity for the spreading of these genes, con-
jugation (Yang et al. 2008) and transformation (Sam-
brook & Russell 2001) experiments were conducted. 
However, the genes did not appear to be transferable by 
transformation or conjugation.
This article describes the first E. coli isolates in Bra-
zil harbouring the qnrS1, qnrB19 and aac(6′)-Ib-cr genes. 
The aac(6′)-Ib-cr-positive isolates, which also produced 
ESBLs, are of particular clinical concern.
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